Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radiosurgery Plus Bevacizumab in Glioblastoma

This study has been terminated.
(Slow Accrual)
Sponsor:
Information provided by (Responsible Party):
Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01086345
First received: March 11, 2010
Last updated: August 12, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)